These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3266338)

  • 1. Differential effects of calcium channel blockade and intracellular calcium antagonism on endothelium-dependent responses of the rat aorta to drugs.
    Olah ME; Rahwan RG
    Pharmacology; 1988; 37(5):305-20. PubMed ID: 3266338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor(s) and calcium antagonists.
    Auch-Schwelk W; Vanhoutte PM
    Z Kardiol; 1989; 78 Suppl 6():120-3. PubMed ID: 2618128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel activation does not increase release of endothelial-derived relaxant factors (EDRF) in rat aorta although tonic release of EDRF may modulate calcium channel activity in smooth muscle.
    Spedding M; Schini V; Schoeffter P; Miller RC
    J Cardiovasc Pharmacol; 1986; 8(6):1130-7. PubMed ID: 2434737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists inhibit contractions to norepinephrine in the rat aorta, in the absence, but not in the presence of the endothelium.
    Auch-Schwelk W; Vanhoutte PM
    Gen Pharmacol; 1991; 22(4):595-602. PubMed ID: 1936893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of calcium relaxation of vascular smooth muscle.
    Wu CC; Bohr DF
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1411-6. PubMed ID: 1951728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The direct effect of levobupivacaine in isolated rat aorta involves lipoxygenase pathway activation and endothelial nitric oxide release.
    Choi YS; Jeong YS; Ok SH; Shin IW; Lee SH; Park JY; Hwang EM; Hah YS; Sohn JT
    Anesth Analg; 2010 Feb; 110(2):341-9. PubMed ID: 19955508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation by endothelium of the responses induced by endothelin-1 and by some of its analogues in rat isolated aorta.
    Topouzis S; Huggins JP; Pelton JT; Miller RC
    Br J Pharmacol; 1991 Feb; 102(2):545-9. PubMed ID: 2015428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of palmitoyl carnitine with the endothelium in rat aorta.
    Dainty IA; Bigaud M; McGrath JC; Spedding M
    Br J Pharmacol; 1990 Jun; 100(2):241-6. PubMed ID: 1696151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular smooth muscle influences the release of endothelium-derived relaxing factor.
    Warren JB; Brady AJ; Taylor GW
    Proc Biol Sci; 1990 Aug; 241(1301):127-31. PubMed ID: 1978339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.
    Saifeddine M; Roy SS; Al-Ani B; Triggle CR; Hollenberg MD
    Br J Pharmacol; 1998 Dec; 125(7):1445-54. PubMed ID: 9884072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta.
    Hutcheson IR; Griffith TM
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H590-6. PubMed ID: 7511348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.
    Haught WH; Yang BC; Lawson DL; Mehta JL
    J Cardiovasc Pharmacol; 1992 May; 19(5):701-8. PubMed ID: 1381767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta.
    Ellis A; Li CG; Rand MJ
    Br J Pharmacol; 2000 Jan; 129(2):315-22. PubMed ID: 10694238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of carbachol on cytosolic calcium levels in vascular endothelium and smooth muscle.
    Sato K; Ozaki H; Karaki H
    J Pharmacol Exp Ther; 1990 Oct; 255(1):114-9. PubMed ID: 2213546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasorelaxant effects of Shunaoxin pill are mediated by NO/cGMP pathway, HO/CO pathway and calcium channel blockade in isolated rat thoracic aorta.
    Huo L; Zhang J; Qu Z; Chen H; Li Y; Gao W
    J Ethnopharmacol; 2015 Sep; 173():352-60. PubMed ID: 26239154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-derived relaxing and contracting factors.
    Rubanyi GM
    J Cell Biochem; 1991 May; 46(1):27-36. PubMed ID: 1874796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions.
    Tang EH; Vanhoutte PM
    Pharmacol Ther; 2009 May; 122(2):140-9. PubMed ID: 19285526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calcium and endothelium in hypertension, cardiovascular disease, and subsequent vascular events.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S6-10. PubMed ID: 1376838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
    Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
    J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.